72 related articles for article (PubMed ID: 25896942)
1. Immunohistochemical evidence of stress and inflammatory markers in mouse models of cutaneous leishmaniosis.
Araujo AP; Giorgio S
Arch Dermatol Res; 2015 Oct; 307(8):671-82. PubMed ID: 25896942
[TBL] [Abstract][Full Text] [Related]
2. Infection by Leishmania amazonensis in mice: a potential model for chronic hypoxia.
Araújo AP; Arrais-Silva WW; Giorgio S
Acta Histochem; 2012 Dec; 114(8):797-804. PubMed ID: 22360823
[TBL] [Abstract][Full Text] [Related]
3. Distinct courses of infection with Leishmania (L.) amazonensis are observed in BALB/c, BALB/c nude and C57BL/6 mice.
Velasquez LG; Galuppo MK; DE Rezende E; Brandão WN; Peron JP; Uliana SR; Duarte MI; Stolf BS
Parasitology; 2016 May; 143(6):692-703. PubMed ID: 26892342
[TBL] [Abstract][Full Text] [Related]
4. Expression of hypoxia-inducible factor-1alpha in the cutaneous lesions of BALB/c mice infected with Leishmania amazonensis.
Arrais-Silva WW; Paffaro VA; Yamada AT; Giorgio S
Exp Mol Pathol; 2005 Feb; 78(1):49-54. PubMed ID: 15596060
[TBL] [Abstract][Full Text] [Related]
5. The influence of low oxygen on macrophage response to Leishmania infection.
Degrossoli A; Arrais-Silva WW; Colhone MC; Gadelha FR; Joazeiro PP; Giorgio S
Scand J Immunol; 2011 Aug; 74(2):165-75. PubMed ID: 21517930
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
[TBL] [Abstract][Full Text] [Related]
7. Long-term cell culture isolated from lesions of mice infected with Leishmania amazonensis: a new approach to study mononuclear phagocyte subpopulations during the infection.
Terreros MJS; de Luna LAV; Giorgio S
Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 29045624
[TBL] [Abstract][Full Text] [Related]
8. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
[TBL] [Abstract][Full Text] [Related]
9. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L
Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340
[TBL] [Abstract][Full Text] [Related]
10. Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host.
Villaseñor-Cardoso MI; Salaiza N; Delgado J; Gutiérrez-Kobeh L; Pérez-Torres A; Becker I
Parasite Immunol; 2008 Aug; 30(8):425-34. PubMed ID: 18507782
[TBL] [Abstract][Full Text] [Related]
11. Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis.
Kückelhaus CS; Kückelhaus SA; Muniz-Junqueira MI
Exp Parasitol; 2011 Mar; 127(3):658-64. PubMed ID: 21176775
[TBL] [Abstract][Full Text] [Related]
12. Recombinant IGFBP-3 inhibits allergic lung inflammation, VEGF production, and vascular leak in a mouse model of asthma.
Kim SR; Lee KS; Lee KB; Lee YC
Allergy; 2012 Jul; 67(7):869-77. PubMed ID: 22563687
[TBL] [Abstract][Full Text] [Related]
13. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
[TBL] [Abstract][Full Text] [Related]
14. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.
Vieira LQ; Goldschmidt M; Nashleanas M; Pfeffer K; Mak T; Scott P
J Immunol; 1996 Jul; 157(2):827-35. PubMed ID: 8752935
[TBL] [Abstract][Full Text] [Related]
15. Propolis reduces Leishmania amazonensis-induced inflammation in the liver of BALB/c mice.
da Silva SS; Mizokami SS; Fanti JR; Miranda MM; Kawakami NY; Teixeira FH; Araújo EJ; Panis C; Watanabe MA; Sforcin JM; Pavanelli WR; Verri WA; Felipe I; Conchon-Costa I
Parasitol Res; 2016 Apr; 115(4):1557-66. PubMed ID: 26711452
[TBL] [Abstract][Full Text] [Related]
16. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
[TBL] [Abstract][Full Text] [Related]
17. Ocular experimental leishmaniasis in C57BL/10 and BALB/c mice induced by Leishmania amazonensis infection.
Calabrese KS; Silva LS; Hardoim DJ; Souza CS; Abreu-Silva AL
Exp Parasitol; 2013 Feb; 133(2):156-61. PubMed ID: 23201219
[TBL] [Abstract][Full Text] [Related]
18. Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin--than on footpad-infected mice.
Felizardo TC; Gaspar-Elsas MI; Lima GM; Abrahamsohn IA
Exp Parasitol; 2012 Jan; 130(1):48-57. PubMed ID: 22019418
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.
Calvopina M; Barroso PA; Marco JD; Korenaga M; Cooper PJ; Nonaka S; Hashiguchi Y
Vaccine; 2006 Jul; 24(27-28):5645-52. PubMed ID: 16621179
[TBL] [Abstract][Full Text] [Related]
20. Short-term protection conferred by Leishvacin® against experimental Leishmania amazonensis infection in C57BL/6 mice.
Carneiro MB; de Andrade e Sousa LM; Vaz LG; Dos Santos LM; Vilela L; de Souza CC; Gonçalves R; Tafuri WL; Afonso LC; Côrtes DF; Vieira LQ
Parasitol Int; 2014 Dec; 63(6):826-34. PubMed ID: 25102355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
